cabozantinib
ipsen
['rcc,(-irccs),(-srcc),(-urcc)', 'cabozantinib', 'renal,(-adrenal)', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'cabopoint']
cabopoint: -cabozantinib demonstrated preliminary efficacy in patients w mrcc after progression on cpi-based combo, irrespective of 1l
#gu23 #medtwitter #kidney 
On the road!
Pursuing to improve global health through sharing knowledge, cancer prevention, and care.  
Medical oncologist @AnkaraUni